Investigating the impact of open label design on patient‐reported outcome results in prostate cancer randomized controlled trials

Investigating the impact of open label design on patient‐reported outcome results in prostate cancer randomized controlled trials

Abstract Background While open‐label randomized controlled trials (RCT) are common in oncology, some concerns have been expressed with regard to Patient‐Reported Outcomes (PRO)‐based claims stemming from these studies. We aimed to investigate the impact of open‐label design in the context of prostat...

Full description

Bibliographic Details
Main Authors: Guillaume Mouillet, Fabio Efficace, Antoine Thiery‐Vuillemin, Emilie Charton, Mieke Van Hemelrijck, Francesco Sparano, Amélie Anota
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:Cancer Medicine
Subjects:
blinded
health‐related quality of life
methodology
patient‐reported outcome
prostate cancer
randomized trials
Online Access:https://doi.org/10.1002/cam4.3335

Internet

https://doi.org/10.1002/cam4.3335

Similar Items